Alpheus Medical
PrivateLast Round
Series B
May 15, 2025
Est. Valuation
$140M
Total Funding Raised
$82M
Company Overview
Alpheus Medical operates in Healthcare & Life Sciences and is based in Chanhassen, Minnesota. Its latest recorded funding round was a Series B round in May 2025.
Alpheus Medical is a biotechnology company developing a sonodynamic therapy (SDT) platform that pairs a tumor-accumulating drug with low-intensity ultrasound to treat solid body cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alpheus Medical Comparables
Compare Alpheus Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SonALAsense | 92% | |
| SonoTarg | 83% | |
| Hemerion Therapeutics | 82% |
For institutional investors. Book with your work email.
Alpheus Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 15, 2025 | ||||
| Series B | May 2, 2025 | ||||
| Series A Extension | Nov 10, 2022 | ||||
| Series A | Nov 17, 2021 | ||||
| Early Funding | Dec 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alpheus Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series A, Series A Extension |
| Action Potential Venture Capital | Series A Extension, Series B, Series A |
| OrbiMed | Series A Extension, Series B, Series A |
| The Sontag Foundation | Series B |
| BrightEdge | Series A, Series A Extension, Series B |
| Samsara BioCapital | Series B |
| HealthQuest Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 83% MoM.
- May 15, 2025
$52M round led by HealthQuest Capital and Samsara BioCapital.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 8, 2026
Alpheus Medical Inc. develops Porphyrin Metabolite Activation (PoMA(TM) therapy through the Alpheus Butterfly trial, which evaluates the investigational therapy in newly diagnosed butterfly glioblastoma patients before standard chemoradiation in Minnesota on Oct 8th '26.
For institutional investors. Book with your work email.
Alpheus Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alpheus Medical's valuation, stock price, and market status.
Is Alpheus Medical a public or private company?
Alpheus Medical is a private company.
What is the current stock price of Alpheus Medical?
Alpheus Medical is a private company, so its shares have no public market price. Caplight tracks Alpheus Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alpheus Medical worth (valuation)?
Alpheus Medical's valuation is estimated at $140.0M based on funding round data.
Can I buy Alpheus Medical stock?
Alpheus Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alpheus Medical's last funding round?
Alpheus Medical's most recent funding round was Series B on May 15, 2025.
Who are the main investors in Alpheus Medical?
Key investors in Alpheus Medical include Action Potential Venture Capital, OrbiMed, Samsara BioCapital, HealthQuest Capital.
Will Alpheus Medical IPO soon?
No public IPO plans have been announced for Alpheus Medical.
How can I track Alpheus Medical secondary market activity?
Caplight tracks bids, offers, and trades in Alpheus Medical's shares on secondary markets.